Homologous and heterologous protection of nonhuman primates by Ebola and Sudan virus-like particles

PloS One
Kelly L WarfieldM Javad Aman

Abstract

Filoviruses cause hemorrhagic fever resulting in significant morbidity and mortality in humans. Several vaccine platforms that include multiple virus-vectored approaches and virus-like particles (VLPs) have shown efficacy in nonhuman primates. Previous studies have shown protection of cynomolgus macaques against homologous infection for Ebola virus (EBOV) and Marburg virus (MARV) following a three-dose vaccine regimen of EBOV or MARV VLPs, as well as heterologous protection against Ravn Virus (RAVV) following vaccination with MARV VLPs. The objectives of the current studies were to determine the minimum number of vaccine doses required for protection (using EBOV as the test system) and then demonstrate protection against Sudan virus (SUDV) and Taï Forest virus (TAFV). Using the EBOV nonhuman primate model, we show that one or two doses of VLP vaccine can confer protection from lethal infection. VLPs containing the SUDV glycoprotein, nucleoprotein and VP40 matrix protein provide complete protection against lethal SUDV infection in macaques. Finally, we demonstrate protective efficacy mediated by EBOV, but not SUDV, VLPs against TAFV; this is the first demonstration of complete cross-filovirus protection using a single component ...Continue Reading

References

Apr 1, 1981·Journal of Clinical Microbiology·J B MoeH W Lupton
Sep 1, 1996·The Journal of Infectious Diseases·M E ConnerM K Estes
Jan 1, 1997·Advances in Experimental Medicine and Biology·M K EstesM E Conner
Feb 13, 1999·The Journal of Infectious Diseases·P FormentyA Widmer
Apr 8, 2000·Current Opinion in Structural Biology·J E Johnson, W Chiu
Mar 6, 2002·The Journal of Experimental Medicine·Sina BavariM Javad Aman
Apr 23, 2002·Journal of Virology·Takeshi NodaYoshihiro Kawaoka
Aug 12, 2003·Expert Review of Vaccines·Florence BoisgéraultClaude Leclerc
Sep 19, 2003·Trends in Microbiology·Rob Noad, Polly Roy
Sep 23, 2003·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Carol O TacketMary K Estes
Dec 16, 2003·Proceedings of the National Academy of Sciences of the United States of America·Kelly L WarfieldSina Bavari
Jan 22, 2004·FEMS Immunology and Medical Microbiology·Dana L SwensonM Javad Aman
May 17, 2005·Journal of Virological Methods·George KallstromM Javad Aman
Jul 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kelly L WarfieldSina Bavari
Dec 6, 2007·The Journal of Infectious Diseases·Kelly L WarfieldSina Bavari
Dec 6, 2007·The Journal of Infectious Diseases·Kelly L WarfieldSina Bavari
Nov 22, 2008·PLoS Pathogens·Jonathan S TownerStuart T Nichol
Jul 11, 2009·Science·Roger W BarretteMichael T McIntosh
Feb 26, 2010·Clinical and Vaccine Immunology : CVI·William D PrattJohn Y Dong
Apr 1, 2010·Current HIV Research·Luigi BuonaguroFranco M Buonaguro
Mar 19, 2011·East African Journal of Public Health·Yokouide AllarangaAdamou Yada
Oct 19, 2011·The Journal of Infectious Diseases·Kelly L Warfield, M Javad Aman
Mar 14, 2012·Proceedings of the National Academy of Sciences of the United States of America·John M DyeWilliam D Pratt
Oct 17, 2012·Proceedings of the National Academy of Sciences of the United States of America·Gene Garrard OlingerLarry Zeitlin
Jun 10, 2014·Proceedings of the National Academy of Sciences of the United States of America·Kelly L WarfieldPeter D Walsh

❮ Previous
Next ❯

Citations

Mar 25, 2016·Expert Review of Vaccines·Robert A Kozak, Gary P Kobinger
Jul 16, 2015·Journal of Translational Medicine·John H CarraSina Bavari
Jun 9, 2016·FEMS Microbiology Reviews·Robin BurkJens H Kuhn
Jul 21, 2016·Journal of Virological Methods·Marga García DuránMaria José Rodríguez
Sep 1, 2016·Annual Review of Virology·M L BoisenL M Branco
Apr 15, 2016·Expert Review of Vaccines·Chad E MireAndrea Marzi
Oct 21, 2016·Human Vaccines & Immunotherapeutics·Yuxiao WangFengcai Zhu
Dec 3, 2016·The Journal of General Virology·Magdalena Formella, Derek Gatherer
Jan 30, 2018·Nature Reviews. Drug Discovery·Robert W CrossThomas W Geisbert
Oct 7, 2017·ILAR Journal·R Carrasco-HernandezSamuel Ponce de León
Oct 23, 2015·Journal of Virology·Gary WongXiangguo Qiu
Mar 24, 2017·Journal of Virology·Marc SchwenekerJürgen Hausmann
May 14, 2020·Vaccines·Huapeng FengYoshihiro Kawaoka
Apr 28, 2017·Virus Genes·Pierce Reynolds, Andrea Marzi
Jun 26, 2018·The Journal of Infectious Diseases·Kelly L WarfieldM Javad Aman
Dec 11, 2019·The Journal of Clinical Investigation·Robert W CrossThomas W Geisbert
Oct 1, 2016·Annual Review of Medicine·Rohan KeshwaraMatthias J Schnell
Jul 25, 2018·Proceedings of the National Academy of Sciences of the United States of America·Saori SakabeMichael B A Oldstone
Dec 7, 2019·Journal of Autoimmunity·Manuel RojasJuan-Manuel Anaya
Mar 19, 2021·Virulence·Satoko Yamaoka, Hideki Ebihara
May 7, 2021·Biologics : Targets & Therapy·Sabrina SchalySatya Prakash

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
column chromatography

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.

Argentine Hemorrhagic Fever

Argentine hemorrhagic fever (AHF) is an endemo-epidemic disease caused by junín virus (JUNV), a member of the arenaviridae family. Discover the latest research on AHF here.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.